# Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

> **NCT05645523** · EARLY_PHASE1 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT05645523
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645523, "Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05645523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*